Safety and Efficacy Study of Oral Fampridine-SR on Walking Ability in Multiple Sclerosis

This study has been completed.
Information provided by Acorda Therapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Multiple Sclerosis
2		Additional conditions recognized in this trial
			Sclerosis
3		More general conditions related to this trial
			Autoimmune Diseases
			Autoimmune Diseases of the Nervous System
			Demyelinating Autoimmune Diseases, CNS
			Demyelinating Diseases
			Immune System Diseases
			Nervous System Diseases
			Pathologic Processes
4		Additional drug interventions recognized in this trial
			4-Aminopyridine
5		More general drug interventions related to this trial
			Cardiovascular Agents
			Membrane Transport Modulators
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Potassium Channel Blockers
			Therapeutic Uses
6		Sponsors listed in this trial
			Acorda Therapeutics